registered capital total baht 765,000,000 and Paid-up capital baht 765,000,000 with 7,650,000 common shares at a baht 100 par share and the Company will hold 16.67 % which amounts to baht 127,525,500 at value
capital baht 765,000,000 with 7,650,000 common shares at a baht 100 par share and the Company will hold 33.33% which amounts to baht 254,974,500 at value 100 baht per share, total of 2,549,745 shares. The
shares Source of fund: Internal cash flow This investment is considered an asset acquisition transaction with the investment value of 22 million Baht or equivalent to 0.006% of total assets (based on
public offerings of two issuing companies concerning filing of application for approval for public offering of shares, registration statement, and draft prospectus (filing).Akekajak failed to perform due
762,160,000 baht (according to the appraisal report of Sasirachada Company Limited on 1 October 2019.) 6. Source of Funding Internal Working Capital 7. Valuation of the investment Par value of ordinary shares
Elimination of the Conflicts of Interest 3. Information on the Connected Transaction of Buying shares in Medical Vision Co., Ltd of KT Medical Service Co., Ltd from Ms. Kanjana Pongpatanadecha. 4. Information
www.ucity.co.th (-Translation-) Ref. No. U.SET 004/2020 31 March 2020 Subject: Acquisition and Disposal of Ordinary Shares in Joint Venture Companies To: The President The Stock Exchange of Thailand U City Public
stock exchange regulations regarding matters such as the distribution of shares to retail investors (free float). SEC Secretary-General Pornanong Budsaratragoon reported to the Prime Minister that in